Mark Ungs

Founder at InterValve, Inc.

Health Technology

Consumer Services

Profile

Mark Ungs is the founder of InterValve, Inc. which he founded in 2008 and where he currently holds the titles of President, Chief Executive Officer & Director.
Mr. Ungs is also the founder of ACTx, Inc. (Georgia).
He previously worked as Vice President-New Business Development at Boston Scientific Corp.
Mr. Ungs completed his undergraduate degree at Oregon State University and earned an MBA from the University of California, Berkeley.

Mark Ungs active positions

Companies	Position	Start
InterValve, Inc. InterValve, Inc. Medical SpecialtiesHealth Technology InterValve, Inc. operates as a medical device company which develops aortic valvuloplasty balloons for treatment of calcific aortic stenosis. Its V8 product is enhanced with leaflet hyperextension without increasing the risk of annulus over-distension. The firm also develops tools for the percutaneous and trans-apical aortic valve replacement procedure. The company was founded by Wes Pedersen, Mark Ungs, Robert S. Schwartz and Robert A. Van Tassel in 2008 and is headquartered in Plymouth, MN.	Founder	2007-12-31
ACTx, Inc. (Georgia)	Founder	-

All active positions of Mark Ungs

Former positions of Mark Ungs

Companies	Position	End
BOSTON SCIENTIFIC CORPORATION	Corporate Officer/Principal	-

See the detail of Mark Ungs's experience

Training of Mark Ungs

Oregon State University	Undergraduate Degree
University of California, Berkeley	Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Mark Ungs's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
BOSTON SCIENTIFIC CORPORATION	Health Technology

Private companies	2
InterValve, Inc. InterValve, Inc. Medical SpecialtiesHealth Technology InterValve, Inc. operates as a medical device company which develops aortic valvuloplasty balloons for treatment of calcific aortic stenosis. Its V8 product is enhanced with leaflet hyperextension without increasing the risk of annulus over-distension. The firm also develops tools for the percutaneous and trans-apical aortic valve replacement procedure. The company was founded by Wes Pedersen, Mark Ungs, Robert S. Schwartz and Robert A. Van Tassel in 2008 and is headquartered in Plymouth, MN.	Health Technology
ACTx, Inc. (Georgia)